Deutsche Bank AG Buys Shares of 77,475 Aveanna Healthcare Holdings Inc. $AVAH

Key Points

• Deutsche Bank initiated a position in Aveanna Healthcare by purchasing 77,475 shares valued at approximately $664,000. Institutional investors and hedge funds collectively own 87.96% of the company.
• Aveanna reported quarterly EPS of $0.22, exceeding analyst expectations of $0.17, while revenue of $670.48 million also topped estimates. Shares opened at $13.46, near their 52-week high of $14.00.
• Analyst sentiment remains positive, with an average “Moderate Buy” rating and a $13.50 price target; however, major shareholders and insiders recently sold shares, including a 2.25 million-share sale by J.H. Whitney Equity Partners V.

Deutsche Bank AG purchased a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 77,475 shares of the company's stock, valued at approximately $664,000.

A number of other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company's stock valued at $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Millennium Management LLC grew its holdings in shares of Aveanna Healthcare by 1,007.1% during the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company's stock valued at $9,107,000 after purchasing an additional 1,014,030 shares during the last quarter. Nuveen LLC grew its holdings in shares of Aveanna Healthcare by 135.9% during the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company's stock valued at $12,838,000 after purchasing an additional 905,316 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in Aveanna Healthcare by 451.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 959,488 shares of the company's stock worth $8,511,000 after purchasing an additional 785,452 shares in the last quarter. Finally, Zimmer Partners LP bought a new position in Aveanna Healthcare in the 4th quarter valued at approximately $6,189,000. Institutional investors and hedge funds own 87.96% of the company's stock.

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $13.46 on Wednesday. The business's 50 day simple moving average is $10.40 and its 200 day simple moving average is $8.19. Aveanna Healthcare Holdings Inc. has a one year low of $5.93 and a one year high of $14.00. The stock has a market capitalization of $2.94 billion, a PE ratio of 10.94, a PEG ratio of 0.84 and a beta of 1.97. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.05. The company had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on AVAH. BMO Capital Markets increased their price target on Aveanna Healthcare from $10.00 to $14.00 and gave the company an "outperform" rating in a research note on Friday, August 14th. Wall Street Zen lowered Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 15th. UBS Group upped their target price on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a "neutral" rating in a report on Friday, August 14th. Barclays increased their target price on Aveanna Healthcare from $9.50 to $15.00 and gave the company an "overweight" rating in a research report on Friday, August 28th. Finally, Royal Bank Of Canada boosted their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an "outperform" rating in a report on Monday, August 24th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Aveanna Healthcare presently has an average rating of "Moderate Buy" and an average target price of $13.50.

Insider Activity at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $11.50, for a total transaction of $25,875,000.00. Following the transaction, the insider owned 12,315,892 shares of the company's stock, valued at $141,632,758. This represents a 15.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Edwin C. Reisz sold 50,000 shares of the company's stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $575,000.00. Following the transaction, the insider directly owned 1,397,897 shares in the company, valued at approximately $16,075,815.50. This trade represents a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 59,904,505 shares of company stock worth $649,301,514. Corporate insiders own 5.30% of the company's stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source